Biosafety device manufacturer suitable for the era of the pandemic – $41 million Attracted investment
R-Zero designs IoT enabled, hospital-grade disinfection solutions for the day-to-day realities of modern businesses.
Produce hospital-grade UVC disinfection equipment with light that neutralizes specific viruses. During the pandemic, the business expanded rapidly, gaining more than 1,000 customers in a short period of time.
Recently, with the acquisition of CoWalker, a company specializing in indoor occupancy sensors, business expansion considering the movement of people and viruses from simple disinfection of air and surfaces.
Funding
R-Zero is the first biosafety technology company dedicated to making the indoor spaces we share, safer and clinically clean. Founded to help organizations protect the health of people they serve, R-Zero is dedicated to developing the most effective and innovative disinfection technologies, to reduce the spread of all infectious diseases. Today, the company is pioneering the first continuous, automated disinfection ecosystem, enabling every organization to measure and manage indoor health risk with the same level of sophistication and technology that’s become standard across virtually every other industry. Informed by data science, built with AI, ML, and IoT connected hardware, R-Zero’s intelligent disinfection platform provides greater visibility, automation and even smarter risk reduction within the indoor spaces where humans spend their time.
General Information
- Headquarters : San Francisco, CA
- Founders : Ben Boyer, Eli Harris, Grant Morgan
- Categories : Healthcare, Medical, Public Safety
- Founded : 2020
Funding
- Investors : DBL Partners, John Doerr, SOSV, World Innovation Lab (WiL)
- Funding Rounds (6) - $56.5M
- Jun 16, 2021 Series B / $41.5M
- Sep 30, 2020 Series A / $15M
- Sep 20, 2020 Series A
- Jun 24, 2020 Seed Round
- Apr 18, 2020 Seed Round
- Apr 15, 2020 Seed Round
Source: R-Zero
👉• Web: https://www.rzero.com/
👉• Video: R-Zero Systems - YouTube
0 Comments